{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:14:27Z","timestamp":1793481267095,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.mycmed.2022.101329","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T12:32:23Z","timestamp":1662553943000},"page":"101329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Simulated vaginal fluid: Candida resistant strains\u2019 biofilm characterization and vapor phase of essential oil effect"],"prefix":"10.1016","volume":"33","author":[{"given":"Liliana","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisa","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2022.101329_bib0001","first-page":"5","article-title":"Treatment of vulvovaginal candidiasis: a review of the literature","volume":"24","author":"Dovnik","year":"2015","journal-title":"Acta Dermatovenerol Alp Panon Adriat"},{"key":"10.1016\/j.mycmed.2022.101329_bib0002","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","article-title":"Vulvovaginal candidiasis: epidemiology, microbiology and risk factors","volume":"42","author":"Gon\u00e7alves","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01065-17","article-title":"Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole","volume":"61","author":"Sherry","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101329_bib0004","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9378(97)80026-9","article-title":"Prevalence of and risk factors for fungal vaginitis caused by non-albicans species","volume":"176","author":"Spinillo","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0005","first-page":"238","article-title":"Prevalence of non-albicans Candida infections in women with recurrent vulvovaginal symptomatology","volume":"3","author":"Mintz","year":"2013","journal-title":"Adv Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101329_bib0006","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/AOG.0b013e31827307b2","article-title":"Fluconazole-resistant candida albicans vulvovaginitis","volume":"120","author":"Marchaim","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0007","article-title":"Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.mycmed.2022.101329_bib0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.mycmed.2022.101329_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/13693780902856626","article-title":"Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis","volume":"48","author":"Auler","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/528521","article-title":"Fungal biofilm resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0011","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolution Technol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0012","unstructured":"Hillery A.M., Lloyd A.W., Swarbrick J. Drug delivery and targeting for pharmacists and pharmaceutical scientists 2001:475."},{"key":"10.1016\/j.mycmed.2022.101329_bib0013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10408444.2021.1903386","article-title":"Simulated biological fluids \u2013 a systematic review of their biological relevance and use in relation to inhalation toxicology of particles and fibres","volume":"51","author":"Innes","year":"2021","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0014","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12906-020-2877-x","article-title":"Evaluation of antimicrobial activity of the hydrolate of Coridothymus capitatus (L.) Reichenb. fil. (Lamiaceae) alone and in combination with antimicrobial agents","volume":"20","author":"Marino","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.mycmed.2022.101329_bib0015","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jam.13282","article-title":"Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?","volume":"121","author":"Bona","year":"2016","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0016","article-title":"Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida","volume":"16","author":"Mandras","year":"2016","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.mycmed.2022.101329_bib0017","first-page":"16","article-title":"Chemical composition and anticandidal effect of three thymus species essential oils from southwest of morocco against the emerging nosocomial fluconazole-resistant strains","volume":"4","author":"Asdadi","year":"2014","journal-title":"J Biol Agric Healthc"},{"key":"10.1016\/j.mycmed.2022.101329_bib0018","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3390\/antibiotics11070977","article-title":"Essential oils as a good weapon against drug-resistant Candida auris","volume":"11","author":"Fernandes","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.mycmed.2022.101329_bib0019","unstructured":"Cosm\u00e9tiques et Huiles Essentielles Bio Florame n.d. https:\/\/fr.florame.com\/ (accessed July 26, 2022)."},{"key":"10.1016\/j.mycmed.2022.101329_bib0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/znc-2021-0002","article-title":"Oregano essential oil inhibits Candida spp. biofilms","volume":"76","author":"Hacioglu","year":"2021","journal-title":"Z Naturforsch Sect C J Biosci"},{"key":"10.1016\/j.mycmed.2022.101329_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac029","article-title":"Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: epidemiology, risk factors and antifungal pattern","volume":"60","author":"Fernandes","year":"2022","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0022","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1099\/mic.0.2007\/012617-0","article-title":"Hypoxic conditions and iron restriction affect the cell-wall proteome of Candida albicans grown under vagina-simulative conditions","volume":"154","author":"Sosinska","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.mycmed.2022.101329_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.mycmed.2022.101329_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2020.151414","article-title":"Effect of progesterone on Candida albicans biofilm formation under acidic conditions: a transcriptomic analysis","volume":"310","author":"Gon\u00e7alves","year":"2020","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-7012(00)00122-6","article-title":"A modified microtiter-plate test for quantification of staphylococcal biofilm formation","volume":"40","author":"Stepanovi\u0107","year":"2000","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.mycmed.2022.101329_bib0026","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00284-010-9649-7","article-title":"In vitro biofilm activity of non-Candida albicans Candida species","volume":"61","author":"Silva","year":"2010","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0027","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/13693780802549594","article-title":"Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition","volume":"47","author":"Silva","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0028","doi-asserted-by":"crossref","DOI":"10.1080\/08927014.2018.1472244","article-title":"Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition","volume":"34","author":"Rodrigues","year":"2018","journal-title":"Biofouling"},{"key":"10.1016\/j.mycmed.2022.101329_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12060568","article-title":"The vaginal-PVPA: a vaginal mucosa-mimicking in vitro permeation tool for evaluation of mucoadhesive formulations","volume":"12","author":"Falavigna","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mycmed.2022.101329_bib0030","unstructured":"Sabouraud Dextrose Broth. Liofilchem\u00ae - Sabouraud dextrose broth - Rev01 \/09022016. (2022) http:\/\/www.liofilchem.net\/login\/pd\/ifu\/402040_IFU.pdf."},{"key":"10.1016\/j.mycmed.2022.101329_bib0031","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/10717544.2014.928760","article-title":"Advanced topical drug delivery system for the management of vaginal candidiasis","volume":"23","author":"Johal","year":"2014","journal-title":"Drug Deliv"},{"key":"10.1016\/j.mycmed.2022.101329_bib0032","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1099\/mic.0.25932-0","article-title":"Quantitative variation of biofilms among strains in natural populations of Candida albicans","volume":"149","author":"Li","year":"2003","journal-title":"Microbiology"},{"key":"10.1016\/j.mycmed.2022.101329_bib0033","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance","volume":"183","author":"Chandra","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mycmed.2022.101329_bib0034","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1021\/mp300408m","article-title":"Interactions of microbicide nanoparticles with a simulated vaginal fluid","volume":"9","author":"J das","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.mycmed.2022.101329_bib0035","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1208\/s12248-015-9814-9","article-title":"Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges","volume":"17","author":"Wen","year":"2015","journal-title":"AAPS J"},{"key":"10.1016\/j.mycmed.2022.101329_bib0036","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.indcrop.2013.07.052","article-title":"Chemical composition and in vitro antibacterial properties of essential oils of four Thymus species from organic growth","volume":"50","author":"Ballester-Costa","year":"2013","journal-title":"Ind Crops Prod"},{"key":"10.1016\/j.mycmed.2022.101329_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2022.114667","article-title":"Comparing the effect of Thymus spp. essential oils on Candida auris","volume":"178","author":"Ribeiro","year":"2022","journal-title":"Ind Crops Prod"},{"key":"10.1016\/j.mycmed.2022.101329_bib0038","article-title":"In vitro and in vivo activities of essential oil from the seed of anethum graveolens L. against Candida spp. Evid.-based complement","volume":"2011","author":"Wang","year":"2011","journal-title":"Altern Med ECAM"},{"key":"10.1016\/j.mycmed.2022.101329_bib0039","first-page":"1","article-title":"Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection","volume":"11","author":"Pietrella","year":"2011","journal-title":"BMC Complement Med Ther"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:58Z","timestamp":1761110518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523322000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1156523322000865"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101329","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simulated vaginal fluid: Candida resistant strains\u2019 biofilm characterization and vapor phase of essential oil effect","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS on behalf of SFMM.","name":"copyright","label":"Copyright"}],"article-number":"101329"}}